Skip to search formSkip to main contentSkip to account menu

Thrombopoietin Receptor Agonists [MoA]

Known as: Thrombopoietin Receptor Agonists 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Discoveries throughout the twentieth century have forged our understanding of platelet production and including the variables… 
2016
2016
Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been… 
2015
2015
Background Idiopathic thrombocytopenic purpura (ITP) is a disease characterised by decreased platelet count. Romiplostim and… 
Review
2013
Review
2013
![Graphic][1] Introduction TRAs increase platelet counts by stimulating the TPO-receptor. A known effect of TRA treatment is… 
2013
2013
ResumenObjetivoAnalizar el coste del tratamiento farmacológico de la trombocitopenia inmune primaria (PTI) con agonistas del…